Fundraising Fox

Kyle Makofka

Investor

Board of Directors at Ardenton Capital Corporation · Chief Restructuring Officer at Hemostemix

Canada

Find your path to Kyle

11 people in our graph share verified history with Kyle — schools, employers, funds. One of them is your warm intro.

Thomas A. SmeenkunlockedKyle: together at Hemostemix (2019)
×10Kyle: together at Ardenton Capital Corporation

About

President and CEO of Ardenton Capital, also listed on the Board of Directors.

Chief Restructuring Officer at Hemostemix

Intro paths

In turn, Kyle can intro founders to Hemostemix's investors below.

Hemostemix's investors · 1

Co-founders at Hemostemix

RBRoger Bergersen
Roger BergersenFounder (of predecessor TheraVitae Inc.)
TAThomas A. Smeenk
Thomas A. SmeenkPresident & CEO, Co-Founder

Experience

  1. Ardenton Capital CorporationChief Executive Officercurrent2021 — presentCanada, USA, and United Kingdom
  2. Kingsman Scientific ManagementPresident and CEOcurrent2005 — presentGreater Calgary Metropolitan Area
  3. Midstream SilicaPresident & CEO2016 — 2022Greater Calgary Metropolitan Area
  4. Aspire Health Science LLCSenior Advisor2016 — 2022Greater Orlando
  5. HemostemixCEO2016 — 2019Greater Calgary Metropolitan Area

Skills & more

Business RestructuresPrivate EquityBusiness DevelopmentBusiness StrategyExecutive ManagementBusiness TransformationProcess ImprovementMergers & Acquisitions (M&A)Business Intelligence (BI)Strategic PlanningFamily Office InvestmentQuality Management Systems
+6 moreProject ManagementCorporate AuditSoftware DevelopmentDeveloping Business SystemsDeveloping TechnologiesProcess Optimization

From Kyle's professional profile.

Colleagues at Ardenton Capital Corporation

Frequently asked questions

Who is Kyle Makofka?
President and CEO of Ardenton Capital, also listed on the Board of Directors.
Where does Kyle Makofka work?
Kyle Makofka is Board of Directors at Ardenton Capital Corporation and Chief Restructuring Officer at Hemostemix.

Shared employers